Creative Biolabs offers high-quality custom service covering the entire CAR-T therapy development process to best suit your technical, program and budget requirements which can greatly assist your research, preclinical investigation and clinical stage development.
LEARN MORECreative Biolabs offers a broad range of early development service, especially for TCR engineered T cell biomarker identification and selection, design, construction, and analysis.
LEARN MORECreative Biolabs now provides world-leading dendritic cell (DC) vaccine development services as part of DC-based immunotherapy to our worldwide clients.
LEARN MOREWe are proud to introduce our innovated TCR-like antibody services, ranging from immunogen production to antibody characterization. We are aiming to accelerate therapeutic antibody drug development for a better tomorrow.
LEARN MORECreative Biolabs can provide customers with professional bispecific T-cell receptor (TCR) development service in a de novo manner.
LEARN MORECreative Biolabs has established a powerful advanced platform which can be used to test your investigational small molecules against CAR-T and tumor cells through cytokine release assays.
LEARN MOREOver years in the field of immunotherapy, Creative Biolabs is more than happy to share our technologies, platforms, and experience to facilitate your projects and push the progress towards clinical trials. Please feel free to contact us for more details and our team will get back to you as soon as possible.
LEARN MORECreative Biolabs now provides world-leading dendritic cell (DC) vaccine development services to speed up our clients' projects for academic and clinical purposes.
LEARN MORECreative Biolabs provides a state-of-the-art mRNA CAR-T Therapy Development Service to address the numerous challenges encountered in traditional CAR-T approaches.
LEARN MOREThe latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION